1. Introduction
===============

Panic disorder (PD) is an anxiety disorder characterized by recurrent unexpected episodes of sudden panic and fear. The unexpected panic attack has no obvious cue or trigger at the time of occurrence. In contrast, an expected panic attack is an attack for which there is an obvious cue or trigger. The frequency and severity of panic attacks vary widely.^\[[@R1]\]^

PD is associated with significant personal, social, and economic costs; fortunately, effective treatments for these conditions exist.^\[[@R2]\]^ Cognitive behavioral therapy (CBT) for PD has proved its effectiveness in previous studies.^\[[@R3],[@R4]\]^ In a meta-analysis examining the efficacy of CBT for PD and/or agoraphobia, Mitte^\[[@R5]\]^ found significant effects of CBT on measures of anxiety and clinically significant changes relative to nontreated control conditions, as well as medium effects for CBT on these measures relative to placebo-controlled treatments.^\[[@R2]\]^ Porter and Chambless^\[[@R2]\]^ identified several pretreatment variables that seems to predict improvement in CBT for PD and/or agoraphobia according to the meta-analysis, the narrative review, and the box score analysis. They found that several factors, such as agoraphobic avoidance, comorbid cluster C personality disorders and traits, functional impairment, and low expectancy of change, consistently predict decreased symptom improvement in CBT among this population. A previous study also showed that CBT targeted at panic attacks with comorbid heart disease produced significant reductions in panic attacks, general anxiety, and depression.^\[[@R6]\]^ Furthermore, as anxiety and depression are severely influenced the disability and burden of cognitive impairments, psychotherapeutic interventions such as adaptive or compensatory strategies targeted at frontosubcortical functions, diaries, or formal cognitive remediation and neurorehabilitation programs not only decrease symptoms, but also disability associated with depression.^\[[@R7]\]^ Despite these promising findings, a substantial minority of patients who undergo CBT for PD and/or agoraphobia fail to show significant symptom improvement; for this reason, many researchers have tried to identify predictors of CBT improvement.^\[[@R2]\]^ To provide more effective treatments for a broad range of psychopathology, it is useful to examine baseline predictors of this psychopathology after CBT for PD.^\[[@R8]\]^

Several studies have also reported that very brief, intense, exposure-based interventions produce outcomes comparable to standard CBT in a matter of weeks,^\[[@R9],[@R10]\]^ or even days.^\[[@R9],[@R11]\]^ In general, standard CBT is delivered in 8 to 12 weekly sessions. However, individuals with part-time jobs or living far from the hospital have difficulties attending weekly treatments, and might refuse a treatment. Thus, brief CBT for PD should be regarded as a possibility for delivering effective treatment. Westling and Öst^\[[@R10]\]^ investigated treatment effects for patients having PDs with or without mild agoraphobia using a 4-session CBT containing cognitive restructuring and interoceptive exposure, which showed significantly decreased anxiety and depression, self-reported panic attacks, agoraphobia, general anxiety, agoraphobic cognitions, anxiety sensitivity, and depression. It is therefore possible to achieve a clinically significant change with fewer sessions.^\[[@R10]\]^ Also, small doses of mindfulness meditation training reduce self-reported psychological stress reactivity.^\[[@R12]\]^ Mindfulness meditation can be used in many forms, but the core of each form is an experiential, comparatively nondiscursive observation of internal and/or external perceptual stimuli as they unfold in real time.^\[[@R13]\]^ Tang et al. found that 5 training sessions on integrative body-mind training was effective in improving cognitive functioning, and in decreasing negative mood and stress-related cortisol levels.^\[[@R14],[@R15]\]^ Despite these studies, very few studies have examined the variety of outcomes of the positive results of brief meditation training reports.^\[[@R14]\]^

In this study, we identified essential treatment factors in mindfulness-based brief CBT for PD. In standard CBT, the benefits of identifying predictors of improvement are perhaps less obvious^\[[@R2]\]^; moreover, no specific predictor for the core part in brief, intensive CBT for PD has yet been reported.^\[[@R8]\]^ Recognizing crucial factors in brief CBT for PD will establish treatment strategies for both standard and brief CBT interventions. Therefore, we investigated predictors to identify crucial aspects in brief CBT that would improve therapeutic approaches for PD. The brief CBT protocols used in this study focused on intensive relaxation and meditation training, and we identified whether this type of brief intervention would be effective in patients with PD. Specifically, we hypothesized that mindfulness-based brief CBT would affect domains of physiologic symptomatology such as palpitations, pounding heart, or accelerated heart rate.

2. Materials and methods
========================

2.1. Participants
-----------------

Data were collected retrospectively at Seoul National University Hospital. Eligible participants were 37 medicated patients (14 men and 23 women) with PD who attended a group CBT program. The psychiatrists provided psychiatric assessment and medication management, and designated brief CBT interventions. The mean patient age was 37.8 ± 10.7 years (men = 37.6 ± 10.72 years and women = 38.0 ± 10.9 years; *P* = .335). None of the participants had an acute medical illness that could have affected psychiatric symptoms during 1 month before CBT. Thirty-three (14 men and 19 women) of the 37 patients (89.2%) who started the CBT program completed all CBT sessions. Twenty-nine patients (12 men and 17 women) completed the self-rating scales, both at pre- and post-CBT levels. The study protocol was approved by the Seoul National University Hospital Institutional Review Board (Seoul, Republic of Korea). The acquisition of the informed consent from the patients was waived due to the retrospective nature of this study.

2.2. CBT procedure
------------------

The brief CBT included a 4-session protocol consisting of a 60-minute lecture and 60-minute relaxation/meditation training, which were specifically designed to manage PD. Treatments were delivered collectively in once-weekly sessions. Treatment was targeted to panic attacks and the directly associated anxiety of panic symptoms, combined with exposure and cognitive restructuring. The main objective of the treatment was exposure to somatic sensations associated with panic attacks. Relaxation/meditation was included because it is a traditional behavioral treatment approach to anxiety-related disorders.

The first session started with psychoeducation about the nature of fear, anxiety, panic symptoms, and agoraphobia, as well as defining the stages of the treatment model and explaining its application to PDs. Participants were administered meditation training and relaxation, followed by education. The second session started with psychoeducation about understanding hyperventilation, meditation training, and muscle relaxation, followed by education. The third session started with psychoeducation about dysfunctional automatic thoughts, followed by a further disputation of the catastrophic interpretation in relation to the patient\'s own list of evidences. After education, meditation training and relaxation were implemented. The fourth session started with psychoeducation about interoceptive exposure and real-life exposure. Participants performed meditation training and relaxation followed by education. The participants were also assigned homework after each session.

2.3. Clinical assessments
-------------------------

Patients answered the self-report clinical assessments at pre- and post-CBT sessions.

### 2.3.1. Panic Disorder Severity Scale

The Panic Disorder Severity Scale (PDSS) is a 5-point scale used to assess PD severity.^\[[@R16]\]^ The participants rated the severity of 7 PD features on a scale ranging from 0 (none) to 4 (extreme). The 7 areas covered were frequency of panic attacks, distress during panic attacks, anticipatory anxiety, agoraphobic fear/avoidance, interoceptive fear/avoidance, work impairment/distress, and impairment of social functioning.^\[[@R8]\]^ The Korean version of PDSS has been reported to have adequate reliability and validity.^\[[@R17]\]^

### 2.3.2. Anxiety Sensitivity Index-Revised

The Anxiety Sensitivity Index-Revised (ASI-R) is a 36-item, expanded version of the original ASI. Each item on a scale ranges from 0 (very little) to 4 (very much).^\[[@R18]\]^ ASI-R consists of 4 lower-order factors, all of which are added to a single higher-order factor. The factors are as follows: fear of respiratory symptoms, fear of publicly observable anxiety reactions, fear of cardiovascular symptoms, and fear of cognitive dyscontrol. The ASI-R is a promising set of parameters for measuring anxiety sensitivity, and the reliability and validity of the Korean version of the ASI-R has been reported.^\[[@R19]\]^

### 2.3.3. Albany Panic and Phobia Questionnaire

The Albany Panic and Phobia Questionnaire (APPQ) is a scale that has been designed to measure the distinct dimensions of fears related to sensation-producing activities, in addition to fears associated with common agoraphobic and social phobic situations.^\[[@R20],[@R21]\]^ The scale consists of 27 items forming 3 subscales, which are interpreted as reflecting fear of agoraphobic situations ("agoraphobia"), fear of social situations ("social phobia"), and fear of activities that produce somatic sensations ("interoceptive"). Higher scores on the APPQ reflected higher levels of a particular fear.

### 2.3.4. State-Trait Anxiety Inventory

The State-Trait Anxiety Inventory (STAI) is a measure of state and trait anxiety.^\[[@R22],[@R23]\]^ The scale includes 20 items for assessing state anxiety and 20 for trait anxiety. All items are rated on a 4-point scale (e.g., from "almost never" to "almost always"). Higher scores indicated greater anxiety.

### 2.3.5. Beck Anxiety Inventory

The Beck Anxiety Inventory (BAI) is used to measure anxiety; it consists of 21 items rated on a 4-point scale regarding the severity of anxiety experienced during the past week.^\[[@R24],[@R25]\]^ Total scores from 0 to 7 indicate a minimal level of anxiety, those from 8 to 15 indicate mild anxiety, those from 16 to 25 indicate moderate anxiety, and those from 26 to 63 indicate severe anxiety.

### 2.3.6. Beck Depression Inventory

The Beck Depression Inventory (BDI) is a 21-item self-reported scale in which each item consists of 4 statements reflecting different levels of severity of a particular depressive symptom experienced during the past week.^\[[@R26],[@R27]\]^ A total score of 0 to 13 is classified as reflecting minimal depression, 14 to 19 as mild depression, 20 to 28 as moderate depression, and 29 to 63 as severe depression.

### 2.3.7. Yale-Brown Obsessive Compulsive Scale symptom checklist

The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) symptom checklist elucidates specific obsessions and compulsions.^\[[@R28]\]^ The scale consists of 8 categories measuring obsessions (aggressive, contamination, sexual, hoarding, religious, symmetry, somatic, and miscellaneous), and 7 areas for compulsions (cleaning, checking, repeating, counting, ordering, hoarding/collecting, and miscellaneous). We used a version of the Y-BOCS symptom checklist that was validated for the Republic of Korea.^\[[@R29]\]^

2.4. Statistical analysis
-------------------------

First, we performed exploratory data analysis to characterize distributions and outliers. Second, a paired *t* test was used to compare clinical rating scales at pretreatment and post-treatment. Effect size was measured using Cohen\'s *d* parameter. Third, Pearson correlation analysis was used to evaluate the associations among clinical assessments. Finally, a multiple linear regression analysis was conducted to identify the unique contribution of clinical features to the prediction of PD symptom reductions using brief CBT. Statistical analyses were performed using the Statistical Package for the Social Sciences software for Windows, version 21.0 (IBM, Armonk, NY). All statistical tests were 2-tailed, and *P* values \<.05 were considered significant.

3. Results
==========

Table [1](#T1){ref-type="table"} shows the participants' clinical characteristics. There were significant decreases in PDSS \[*t*(28) = 4.999, *P* \< .001\], ASI-R-Respiration \[*t*(28) = 2.986, *P* = .006\], ASI-R-Publicly \[*t*(28) = 3.343, *P* = .002\], ASI-R-Cardiovascular \[*t*(28) = 4.190, *P* \< .001\], ASI-R-Cognitive dyscontrol \[*t*(28) = 3.680, *P* = .001\], ASI-R-Total \[*t*(28) = 4.793, *P* \< .001\], APPQ-Agoraphobia \[*t*(27) = 3.280, *P* = .003\], APPQ-Total \[*t*(28) = 2.318, *P* = .028\], STAI-State anxiety \[*t*(23) = 4.360, *P* \< .001\], STAI-Trait anxiety \[*t*(24) = 3.392, *P* = .002\], BAI \[*t*(27) = 3.217, *P* = .003\], and BDI \[*t*(27) = 4.131, *P* \< .001\] scores.

###### 

Pre- and post-cognitive behavioral therapy clinical scale scores in patients with panic disorders.

![](medi-97-e12422-g001)

Table [2](#T2){ref-type="table"} shows correlations between the baseline clinical self-reported scales of patients. We added a delta PDSS variable to determine the critical features in panic symptom reductions during brief-intensive CBT. Delta PDSS scores were positively correlated with ASI-R-Cardiovascular (*r* = 0.513, *P* = .004) and ASI-R-Total (*r* = 0.430, *P* = .020) scores. In addition, there were significantly positive associations between panic-related measures and anxiety-related variables. Age was negatively correlated with ASI-R-Publicly (*r* = −0.389, *P* = .019), ASI-R-Cognitive dyscontrol (*r* = −0.496, *P* = .002), ASI-R Total (*r* = −0.337, *P* = .044), APPQ-Social phobia (*r* = −0.451, *P* = .006), STAI-State anxiety (*r* = −0.478, *P* = .004), STAI-Trait anxiety (*r* = −0.441, *P* = .009), and BAI (*r* = −0.382, *P* = .024).

###### 

Correlations between clinical scales at baseline.
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Table [3](#T3){ref-type="table"} lists the predictors for essential treatment features for the improvement of panic symptoms. Based on the results of correlation analyses, we set ASI-R cardiovascular subscales and ASI-R total scores at baseline as independent variables, and the delta PDSS (pre-PDSS score minus post-PDSS score) as a dependent variable. The baseline ASI-R-cardiovascular subscale score predicted the delta PDSS score (*β* = 0.513, *P* = .004); no other variable was significant.

###### 

Stepwise multiple linear regression analysis for the effect of a unique predictor of improvement in panic symptoms.
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4. Discussion
=============

The present study examined the crucial parts of brief CBT for PD, and provided evidence of anxiety sensitivity for fear of cardiovascular symptoms subscale at baseline that predicted panic symptom reductions in PD. The results were consistent with previous findings that ASI-physical scores were strongly associated with PD symptoms.^\[[@R8],[@R30]\]^ High scores on the ASI-physical concerns factor denoted worry about the physical health consequences of arousal sensations (e.g., heart palpitations leading to a heart attack).^\[[@R30]\]^ Anxiety sensitivity has been shown to be significantly associated with the development of panic attack frequency and the incidence of panic, independently of negative effects.^\[[@R31],[@R32]\]^ Panic symptoms were especially pronounced for high ASI patients who had been trained to monitor their heart rate before the challenge; hence, attention to sensations among those who fear them was notably panicogenic.^\[[@R33]\]^ The ASI is a better predictor of response to biological challenges than are measures of general trait anxiety.^\[[@R33]--[@R35]\]^ The strong association between elevated ASI scores and PDs has been replicated many times,^\[[@R33],[@R36]\]^ and ASI item analyses have indicated that fears of cardiorespiratory symptoms are especially prominent in PD.^\[[@R33],[@R37]\]^ These results supported the suggestion that physical concerns are most closely associated with PD,^\[[@R30],[@R38]\]^ specifically, ASI-R-fears of cardiovascular symptoms may be an important predictor of the clinical course of PD, but we could not find ASI-R-fears of respiratory symptoms predicting reduction in panic symptoms in this study.

We also observed clinically significant reductions in self-rated PD symptoms, anxiety, and depression after a 1-month CBT intervention. The results of the present study showed that patients significantly improved from pre- to post-treatment on self-rated measures. These results were consistent with previous studies reporting the effectiveness of short-term CBT for PD.^\[[@R10],[@R39]\]^ A brief four sessions of CBT for patients having PD yielded a significant improvement of panic symptoms at 4 weeks of post-treatment and 6-month follow-up.^\[[@R10]\]^ In addition, treatment effects of a 2 days of brief intensive group CBT for patients with agoraphobia with panic attacks were also maintained after 1-year follow-up.^\[[@R11]\]^ Brief mindfulness meditation intervention also induced greater changes when compared to the sham meditation and control groups in distressed moods and heart rates, suggesting that brief mindfulness meditation training was effective for reducing overall negative moods, including depression, tension, fatigue, confusion and anxiety, and for lowering heart rate.^\[[@R14]\]^ Moreover, an empirical study revealed that higher baseline heartbeat perception-accuracy could lead to enhanced therapeutic gains concerning agoraphobic behaviors and beliefs, which adopted brief form of standard CBT for PD with agoraphobia.^\[[@R40]\]^

We also found that age was negatively correlated with anxiety-related variables. This observation was consistent with the finding that the severity of anxiety symptoms during episodes of anxiety disorders decreased over time for each of the anxiety disorders examined (PD, generalized anxiety disorder, and social phobia), and these findings added to the limited empirical data available on the long-term course of anxiety disorders.^\[[@R41]\]^ However, whether anxiety sensitivity also becomes more important for the development of anxiety-related psychopathology in a linear fashion as adults age is unclear.^\[[@R31]\]^ Our results did not include information about the duration of illnesses, so this negative association should be investigated in future research with detailed demographic information. Moreover, we did not observe a significant reduction in APPQ-Social phobia and APPQ-Interoceptive subscales; these results might be due to the psychometric properties of the APPQ subscales. The APPQ scale was developed for identification of overt activities feared by individuals with PD and PD with agoraphobia, so the scale measured the fear of overt activities associated with somatic sensations,^\[[@R42]\]^ whereas ASI was indicative of beliefs about the personal consequences of experiencing anxieties.^\[[@R43]\]^ ASI is unique, not only when compared with trait anxiety but also when compared with the much broader personality trait of negative effects.^\[[@R43]\]^ Individuals who did not experience serious anxieties or panic attacks could possibly have high levels of anxiety sensitivity. This study involved patients with PD who have relatively less severe panic symptoms, so the participants' characteristics might have affected the present results.

Our findings suggested that behavioral aspects, particularly managing fear of cardiovascular symptoms, should be included in brief, intensive CBT to improve therapeutic efficiency. Also, we concluded that this type of brief intervention could be particularly effective for PD patients who suffered from cardiovascular symptoms. More specifically, increasing awareness of heartbeat perception through heart rate biofeedback strategies would facilitate habituation during exposure session,^\[[@R40]\]^ this approach could help perceiving their own heartbeats more precisely. In a heartbeat perception task, known as "mental tracking,"^\[[@R44]\]^ participants are asked to silently count all heartbeats they feel in their body, without taking their pulse.^\[[@R45]\]^ To the best of our knowledge, no study has investigated the treatment effect in mindfulness-based brief CBT containing "mental tracking" paradigm, it would be interesting research topic concerning therapeutic efficacy in PD population.

This study had several limitations. First, the study did not include a control group, and analyses of the effects of brief CBT relied on within-group changes. We could not conclude that CBT was responsible for the changes shown in the participants. Second, our sample was somewhat more functional than the PD population at large, as evidenced by the relatively mild panic severities and anxiety/depression levels. Thus, brief CBT may not suitable for all individuals with PD. Third, there was no assessment to determine whether the effects of brief CBT were as effective as those of standard treatment.

In conclusion, our results indicated that managing anxiety sensitivity for fear of cardiovascular symptoms may be a crucial factor in PD symptom reduction. Therefore, it might be useful to emphasize a behavioral approach, especially physiological symptom reduction, in brief CBT sessions. In addition, it is possible that patient help themselves to perceive their own heartbeat accurately in brief CBT session, PD patients who have severe fear of cardiovascular symptoms will benefit the most from this type of brief CBT intervention.
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